Net profit of Beryl Drugs declined 94.59% to Rs 0.02 crore in the quarter ended June 2025 as against Rs 0.37 crore during the previous quarter ended June 2024. Sales declined 23.36% to Rs 4.79 crore in the quarter ended June 2025 as against Rs 6.25 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 4.79 | 6.25 | -23 |
| OPM % | 11.48 | 15.84 | - |
| PBDT | 0.45 | 0.78 | -42 |
| PBT | 0.07 | 0.50 | -86 |
| NP | 0.02 | 0.37 | -95 |